Hepatitis b virus surface antigen inhibitor
AssigneeFujian Akeylink Biotechnology Co., Ltd.
InventorsCharles Z. DING, Fei SUN, Yanbin HU, Shuhui CHEN
Life of this patent
Estimating the term…
Abstract
Disclosed in the present invention is a new 11-oxo-7,11-dihydro-6h-benzo-[f]pyrido[1,2-d][1,4]azepine oxepin-10-carboxylic acid derivative serving as a hepatitis B virus surface antigen inhibitor. Specifically disclosed are a compound represented by formula (V) or a pharmaceutically acceptable salt thereof, and applications of the compound represented by formula (V) or the pharmaceutically acceptable salt thereof and a pharmaceutical composition thereof in the treatment of viral hepatitis B.
Claims4
A compound or a pharmaceutically acceptable salt thereof, wherein the compound has a structure of
Dependencies are inferred from the claim text.